PMID: 9171368May 15, 1997Paper

Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos

Genes & Development
T LudwigA Efstratiadis

Abstract

Mutations of the human BRCA1 and BRCA2 genes encoding tumor suppressors have been implicated in inherited predisposition to breast and other cancers. Disruption of the homologous mouse genes Brca1 and Brca2 by targeting showed that they both have indispensable roles during embryogenesis, because nullizygous embryos become developmentally retarded and disorganized, and die early in development. In Brca1 mutants, the onset of abnormalities is earlier by one day and their phenotypic features and time of death are highly variable, whereas the phenotype of Brca2 null embryos is more uniform, and they all survive for at least 8.5 embryonic days. Observations with Brca1/Brca2 double nullizygotes raise the possibility that the two developmental pathways could be linked. Interestingly, the impact of the Brca1 or Brca2 null mutation is less severe in a p53 null background.

References

Sep 1, 1992·Trends in Genetics : TIG·L Avery, S Wasserman
May 1, 1988·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Y HayashiT Hoshino
Aug 1, 1995·Current Biology : CB·J F ArmstrongA R Clarke
Jun 20, 1995·Proceedings of the National Academy of Sciences of the United States of America·M SchutteJ M Trent
Mar 1, 1995·Trends in Genetics : TIG·A J Copp
Apr 10, 1995·American Journal of Medical Genetics·M J SellerG S Tint
Jun 15, 1995·Nature·M BoydD M Black
Feb 1, 1995·British Journal of Cancer·V OrphanosM Santibanez-Koref
Jul 1, 1994·Nature Genetics·T JacksR A Weinberg
Jan 1, 1994·Current Biology : CB·T JacksR A Weinberg
Jun 21, 1994·Proceedings of the National Academy of Sciences of the United States of America·K IwabuchiS Fields
Jun 11, 1993·Annals of the New York Academy of Sciences·P S Freemont
Aug 27, 1993·Cell·J A KreidbergR Jaenisch
Jan 1, 1995·Human Molecular Genetics·C I Szabo, M C King
Jan 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·S G FischerA Efstratiadis
Mar 1, 1996·Nature Genetics·J T HoltR A Jensen
Mar 1, 1996·Nature Genetics·S V TavtigianD E Goldgar
Dec 1, 1995·Human Molecular Genetics·C F XuE Solomon
Jun 1, 1996·Nature Genetics·J M LancasterP A Futreal
Jun 1, 1996·Nature Genetics·Y MikiY Nakamura
May 1, 1996·Genomics·R W DeBry, M F Seldin
May 1, 1996·Nature Genetics·P BorkM Nilges
Jul 1, 1996·Nature Genetics·E V KooninP Bork
Jun 1, 1996·Lancet·D P KelsellD T Bishop
Feb 1, 1996·Seminars in Cancer Biology·C F Xu, E Solomon

❮ Previous
Next ❯

Citations

May 26, 1999·The Journal of Pathology·K F Macleod, T Jacks
May 11, 2000·Seminars in Surgical Oncology·P O ChappuisW D Foulkes
Nov 4, 2000·International Journal of Cancer. Journal International Du Cancer·R BachelierA Vincent
Aug 5, 2000·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·C X Deng, S G Brodie
Jan 12, 2005·The Journal of Pathology·Guillermina Lozano, Gerard P Zambetti
Feb 19, 2011·Journal of Mammary Gland Biology and Neoplasia·Ewa Malgorzata Michalak, Jos Jonkers
Jun 3, 2004·Biochimica Et Biophysica Acta·Manuela Santarosa, Alan Ashworth
Jan 17, 2004·Biochimie·Filippo RosselliPietro Pichierri
May 29, 2004·Mutation Research·Andrej Dudás, Miroslav Chovanec
Oct 1, 2003·Trends in Endocrinology and Metabolism : TEM·Eliot M RosenItzhak D Goldberg
Apr 23, 2003·Journal of Molecular Biology·Cecilia LundinThomas Helleday
May 30, 2001·Mutation Research·L H Thompson, D Schild
Nov 13, 2002·Mutation Research·Larry H Thompson, David Schild
Aug 1, 1998·Mutation Research·S Venkatachalam, L A Donehower
Feb 17, 2001·Journal of Biochemical and Biophysical Methods·E GrossN Arnold
Feb 25, 2000·Cancer Genetics and Cytogenetics·H TworekR A DiCioccio
Oct 5, 2001·Trends in Genetics : TIG·S G Brodie, C X Deng
Sep 1, 1997·Trends in Genetics : TIG·A V Anagnostopoulos
Feb 1, 2000·Trends in Genetics : TIG·P L WelcshM C King
Mar 20, 2002·Biochimie·Ralph Scully, Nadine Puget
Dec 2, 1999·Molecular and Cellular Endocrinology·M Schuyer, E M Berns
Jun 5, 2003·Biochimica Et Biophysica Acta·Irmgard Irminger-Finger
May 10, 2001·Current Opinion in Cell Biology·A R Venkitaraman
Aug 15, 2000·The International Journal of Biochemistry & Cell Biology·C Morrison, S Takeda
Jul 29, 1998·Molecular Medicine Today·J Feunteun
Dec 5, 2002·Mutation Research·Marion KubistaMarkus Hengstschläger
May 11, 2010·Nature Structural & Molecular Biology·Peter BouwmanJos Jonkers
Jul 7, 2011·Nature Structural & Molecular Biology·William K Holloman
Dec 11, 2007·Oncogene·T Thorslund, S C West
Sep 1, 2001·Internal Medicine Journal·K A Phillips
Dec 18, 2008·Proceedings of the National Academy of Sciences of the United States of America·Latarsha J ReidThomas Ludwig
Apr 28, 2010·Proceedings of the National Academy of Sciences of the United States of America·Sridharan RajagopalanAlan R Fersht
Oct 12, 2011·Proceedings of the National Academy of Sciences of the United States of America·Hiroyuki KonishiBen Ho Park

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.